Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details) - Schedule of deferred tax assets and liabilities

v3.22.1
Income Taxes (Details) - Schedule of deferred tax assets and liabilities - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Deferred tax assets:    
Net operating losses carry forward $ 36,405 $ 33,955
Share-based compensation 1,213 1,689
Research and development/orphan drug credits 14,536 12,638
Intangibles 10,426 7,873
Others 19 19
Less: valuation allowance (62,599) (56,174)
Deferred tax assets, net